---
$id: https://graph.org.ai/products/commodity/51112009
$type: Product
source: UNSPSC
code: "51112009"
title: "Sunitinib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sunitinib

**UNSPSC Code**: 51112009
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor and angiogenesis activator inhibitor with the molecular formula C22H27FN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V99T50803M, chemically known as 1h-pyrrole-3-carboxamide, n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl- but generally known as sunitinib, which bears US NIH Compound Identifier 5329102. European Medicines Agency schedules Sunitinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22321. The term SUNITINIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, No. 1, 2006, List 55). World Health Organization schedules sunitinib in its Anatomical Therapeutic Chemical (ATC) Classification. SUNITINIB is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sunitinib under HS 29337900 and SITC 51561. As of Q4 2014, SUNITINIB remains the US FDA Preferred Term for this commodity. Sunitinib bears US NLM identifiers UMLS ID C1176020 and NCI Concept Code C71622. SMILES: FC1CC2/C(=C/C3[NH]C(C(C3C)C(=O)NCCN(CC)CC)C)C(=O)NC2CC1.

